Peptide-mediated interference with influenza A virus polymerase

Journal of Virology

Volumn 81, Issue 14, 2007, Pages 7801-7804

  Ghanem, Alexander ^a   Mayer, Daniel ^a   Chase, Geoffrey ^a   Tegge, Werner ^b   Frank, Ronald ^b   Kochs, Georg ^a   García Sastre, Adolfo ^c   Schwemmle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE;

ARTICLE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; DNA-DIRECTED RNA POLYMERASES; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; PEPTIDES; VIRUS REPLICATION;

INFLUENZA A VIRUS;

EID: 34447263302     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00724-07     Document Type: Article

References (21)

1. Biswas, S. K., and D. P. Nayak. 1996. Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J. Virol. 70:6716-6722.
2. Crescenzo-Chaigne, B., N. Naffakh, and S. van der Werf. 1999. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo. Virology 265:342-353.
3. De Clercq, E. 2004. Antivirals and antiviral strategies. Nat Rev. Microbiol. 2:704-720.
4. Dostmann, W. R., C. Nickl, S. Thiel, I. Tsigelny, R. Frank, and W. J. Tegge. 1999. Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper. Pharmacol. Ther. 82:373-387.
5. Fawell, S., J. Seery, Y. Daikh, C. Moore, L. L. Chen, B. Pepinsky, and J. Barsoum. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91:664-668.
6. Gabriel, G., B. Dauber, T. Wolff, O. Planz, H. D. Klenk, and J. Stech. 2005. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl. Acad. Sci. USA 102:18590-18595.
7. Gonzalez, S., T. Zurcher, and J. Ortin. 1996. Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res. 24:4456-4463.
8. Hartlieb, B., J. Modrof, E. Muhlberger, H. D. Klenk, and S. Becker. 2003. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J. Biol. Chem. 278:41830-41836.
9. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
10. Jambrina, E., J. Barcena, O. Uez, and A. Portela. 1997. The three subunits of the polymerase and the nucleoprotein of influenza B virus are the minimum set of viral proteins required for expression of a model RNA template. Virology 235:209-217.
11. Loregian, A., and D. M. Coen. 2006. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem. Biol. 13:191-200.
12. Maroun, R. G., S. Gayet, M. S. Benleulmi, H. Porumb, L. Zargarian, H. Merad, H. Leh, J. F. Mouscadet, F. Troalen, and S. Fermandjian. 2001. Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers. Biochemistry 40:13840-13848.
13. Ohtsu, Y., Y. Honda, Y. Sakata, H. Kato, and T. Toyoda. 2002. Fine mapping of the subunit binding sites of influenza virus RNA polymerase. Microbiol. Immunol. 46:167-175.
14. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N- trifluoroacetylneuraminic acid (FANA); mechanism of action. J Gen. Virol. 33:159-163.
15. Paragas, J., J. Talon, R. E. O'Neill, D. K. Anderson, A. Garcia-Sastre, and P. Palese. 2001. Influenza B and C virus NEP (NS2) proteins possess nuclear export activities. J. Virol. 75:7375-7383.
16. Perez, D. R., and R. O. Donis. 1995. A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J. Virol. 69:6932-6939.
17. Perez, D. R., and R. O. Donis. 2001. Functional analysis of PA binding by influenza A virus PB1: effects on polymerase activity and viral infectivity. J. Virol. 75:8127-8136.
18. Pilger, B. D., C. Cui, and D. M. Coen. 2004. Identification of a small molecule that inhibits herpes simplex virus DNA polymerase subunit interactions and viral replication. Chem. Biol. 11:647-654.
19. Pleschka, S., R. Jaskunas, O. G. Engelhardt, T. Zurcher, P. Palese, and A. Garcia-Sastre. 1996. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:4188-4192.
20. Poole, E., D. Elton, L. Medcalf, and P. Digard. 2004. Functional domains of the influenza A virus PB2 protein: identification of NP- and PB1-binding sites. Virology 321:120-133.
21. Vives, E., J. P. Richard, C. Rispal, and B. Lebleu. 2003. TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci. 4:125-132.